You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 886 Targeting VSIG4, a novel macrophage checkpoint, repolarizes suppressive macrophages which induces an inflammatory response in primary cell in vitro assays and fresh human tumor cultures

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
886 Targeting VSIG4, a novel macrophage checkpoint, repolarizes suppressive macrophages which induces an inflammatory response in primary cell in vitro assays and fresh human tumor cultures
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to October 2024

AbstractFullPdf
Nov 2021286031
Dec 2021206031
Jan 2022428040
Feb 2022492045
Mar 2022626040
Apr 2022438048
May 2022286067
Jun 2022182047
Jul 2022216030
Aug 2022236074
Sep 2022280052
Oct 2022212039
Nov 2022228033
Dec 2022120020
Jan 2023154026
Feb 2023106022
Mar 2023142020
Apr 2023102016
May 2023132022
Jun 2023184033
Jul 2023108027
Aug 2023140035
Sep 202392016
Oct 2023178031
Nov 2023140023
Dec 202310809
Jan 20247606
Feb 202448014
Mar 202496022
Apr 20247807
May 202494010
Jun 202473014
Jul 202492015
Aug 20246508
Sep 202450011
Oct 202472017
Total656601001